Modulation of lymphocyte phenotype and function by immunoglobulins

British Journal of Dermatology

Volumn 154, Issue 2, 2006, Pages 225-230

  Kirschbaum, J ^a   Forschner, K ^a   Rasche, C ^a   Worm, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atopic dermatitis; B cells; Cytokines; Immunoglobulins; T cells

Indexed keywords

CD23 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4;

ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HEALTH STATUS; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 33644898826     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07005.x     Document Type: Article

References (32)

1. Leung DY Bloom JW Update on glucocorticoid action and resistance J Allergy Clin Immunol 2003 111 3 22
2. Gelfand EW Landwehr LP Esterl B Mazer B Intravenous immune globulin; an alternative therapy in steroid-dependent allergic diseases Clin Exp Immunol 1996 104 Suppl. 1 61 6
3. Jolles S Hughes J Rustin M The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature Br J Dermatol 2000 142 551 4
4. Huang JL Lee WY Chen LC et al. Changes of serum levels of interleukin-2, intracellular adhesion molecule-1 and Th1 and Th2 cells in severe atopic dermatitis after intravenous immunoglobulin therapy Ann Allergy Asthma Immunol 2000 84 345 52
5. Mouthon L Kaveri SV Spalter SH et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases Clin Exp Immunol 1996 104 Suppl. 1 3 9
6. Jolles S Hughes J Whittaker S Dermatological uses of high-dose intravenous immunoglobulin Arch Dermatol 1998 134 80 6
7. Jolles S A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis Clin Exp Dermatol 2002 27 3 7
8. Basta M Dalakas MC High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments J Clin Invest 1994 94 1729 35
9. Basta M Modulation of complement-mediated immune damage by intravenous immune globulin Clin Exp Immunol 1996 104 Suppl. 1 21 5
10. Andersson J Skansen-Saphir U Sparrelid E Andersson U Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages Clin Exp Immunol 1996 104 Suppl. 1 10 20
11. 2+-dependent signal transduction through Fc gamma receptors in B lymphocytes Scand J Immunol 1994 40 37 42
12. Amran D Renz H Lack G et al. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin Clin Immunol Immunopathol 1994 73 180 6
13. Modiano JF Amran D Lack G et al. Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobulin Clin Immunol Immunopathol 1997 83 77 85
14. Jolles S Hughes J Rustin M Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis J Am Acad Dermatol 1999 40 121 3
15. Kazatchkine MD Dietrich G Hurez V et al. V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIG) Immunol Rev 1994 139 79 107
16. Trautmann A Akdis M Kleemann D et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis J Clin Invest 2000 106 25 35
17. Viard I Wehrli P Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 1998 282 490 3
18. Cebrian M Yague E Rincon M et al. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes J Exp Med 1988 168 1621 37
19. Moretta A Poggi A Pende D et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta J Exp Med 1991 174 1393 8
20. Hathcock KS Hodes RJ Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses Adv Immunol 1996 62 131 66
21. Lenschow DJ Walunas TL Bluestone JA CD28/B7 system of T cell costimulation Annu Rev Immunol 1996 14 233 58
22. Yu P Kosco-Vilbois M Richards M et al. Negative feedback regulation of IgE synthesis by murine CD23 Nature 1994 369 753 6
23. Aubry JP Pochon S Graber P et al. CD21 is a ligand for CD23 and regulates IgE production Nature 1992 358 505 7
24. Frotscher B Anton K Worm M Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors J Invest Dermatol 2002 119 1059 64
25. Lubbe J Secondary infections in patients with atopic dermatitis Am J Clin Dermatol 2003 4 641 54
26. Simon HU Späth PJ IVIG - mechanisms of action Allergy 2003 58 543 52
27. Simon MM Waring P Lobigs M et al. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis J Immunol 2000 165 3663 72
28. Takei S Arora YK Walker SM Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens J Clin Invest 1993 91 602 7
29. Jirapongsananuruk O Hofer MF Trumble AE et al. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis J Immunol 1998 160 4622 7
30. Oberwalleney G Henz BM Worm M Expression and functional role of co-stimulatory molecules in CD40+ IL-4-stimulated B cells from atopic and non-atopic donors Acta Derm Venereol (Stockh) 2000 80 287 91
31. Daeron M Latous S Malbec O et al. The same tyrosine-based inhibition motif, in the intracytoplasmatic domain of Fc gamma RIIB, regulates negatively BCR, TCR, and FcR-dependent cell activation Immunity 1995 3 635 46
32. Rabinovitch N Gelfand EW Leung DY The role of immunoglobulin therapy in allergic diseases Allergy 1999 54 662 8